From the Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202 and.
J Biol Chem. 2013 Oct 4;288(40):29036-45. doi: 10.1074/jbc.M113.486753. Epub 2013 Aug 13.
Alterations in mitochondrial protein acetylation are implicated in the pathophysiology of diabetes, the metabolic syndrome, mitochondrial disorders, and cancer. However, a viable mechanism responsible for the widespread acetylation in mitochondria remains unknown. Here, we demonstrate that the physiologic pH and acyl-CoA concentrations of the mitochondrial matrix are sufficient to cause dose- and time-dependent, but enzyme-independent acetylation and succinylation of mitochondrial and nonmitochondrial proteins in vitro. These data suggest that protein acylation in mitochondria may be a chemical event facilitated by the alkaline pH and high concentrations of reactive acyl-CoAs present in the mitochondrial matrix. Although these results do not exclude the possibility of enzyme-mediated protein acylation in mitochondria, they demonstrate that such a mechanism may not be required in its unique chemical environment. These findings may have implications for the evolutionary roles that the mitochondria-localized SIRT3 deacetylase and SIRT5 desuccinylase have in the maintenance of metabolic health.
线粒体蛋白乙酰化的改变与糖尿病、代谢综合征、线粒体疾病和癌症的病理生理学有关。然而,导致线粒体广泛乙酰化的可行机制尚不清楚。在这里,我们证明线粒体基质的生理 pH 值和酰基辅酶 A 浓度足以在体外引起剂量和时间依赖性、但与酶无关的线粒体和非线粒体蛋白的乙酰化和琥珀酰化。这些数据表明,线粒体中的蛋白质酰化可能是一种化学事件,由线粒体基质中存在的碱性 pH 值和高浓度反应性酰基辅酶 A 促进。尽管这些结果不排除线粒体中酶介导的蛋白质酰化的可能性,但它们表明在其独特的化学环境中可能不需要这种机制。这些发现可能对 SIRT3 去乙酰化酶和 SIRT5 脱琥珀酰化酶在维持代谢健康方面在线粒体中发挥的进化作用具有重要意义。
PLoS One. 2016-12-29
Nat Rev Mol Cell Biol. 2025-8-19
Nat Commun. 2025-7-1
Results Probl Cell Differ. 2025
Front Cell Infect Microbiol. 2025-5-15
Nat Chem Biol. 2025-3-26
J Chem Theory Comput. 2008-6
J Chem Theory Comput. 2011-7-12
Mol Cell. 2013-6-27
Mol Cell. 2012-11-29